Interpreting clinical trials in lung cancer: impact of methodology and endpoints.

Interpreting clinical trials in lung cancer: impact of methodology and endpoints.

Item
http://www.wikidata.org/entity/Q36858748
Quality of life assessment as a predictor of survival in non-small cell lung cancerPrognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancerEndpoints in advanced breast cancer: methodological aspects & clinical implications.Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.Quality of life research in neuro-oncology: a quantitative comparison.Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysisReporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.Association between changes in quality of life scores and survival in non-small cell lung cancer patients.
P2860

Interpreting clinical trials in lung cancer: impact of methodology and endpoints.

Item
http://www.wikidata.org/entity/Q36858748
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
type
label
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
prefLabel
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P577
P698
P356
P1433
P1476
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
@en
P2093
P304
P31
P356
10.1097/01.JTO.0000269734.27047.3E
P478
P577
P698